Anabella Villalobos
Vermogen: 58 500 $ op 30-06-2026
Vermogen: 58 500 $ op 30-06-2026
Anabella Villalobos currently works at Coya Therapeutics, Inc., as Independent Director from 2021.
Dr. Villalobos also formerly worked at Biogen, Inc., as SVP-Biotherapeutics & Medicinal Sciences from 2017 to 2025 and Pfizer Inc., as Vice President from 1989 to 2017.
Dr. Villalobos received her doctorate degree from the University of Kansas and undergraduate degree from the University of Panama.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-05-2026 | 10.000 ( 0,04% ) | 58 500 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| COYA THERAPEUTICS, INC. | Directeur/Bestuurslid | 25-05-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2025 |
| PFIZER INC. | Corporate Officer/Principal | 01-01-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Panama
University of Panama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coya Therapeutics, Inc.
Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau